NASDAQ:SMED - Sharps Compliance Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $15.50
  • Forecasted Upside: 21.76 %
  • Number of Analysts: 4
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 4 Buy Ratings
  • 0 Strong Buy Ratings
$12.73
▼ -0.46 (-3.49%)
1 month | 3 months | 12 months
Get New Sharps Compliance Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for SMED and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for SMED

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
$15.50
▲ +21.76% Upside Potential
This price target is based on 4 analysts offering 12 month price targets for Sharps Compliance in the last 3 months. The average price target is $15.50, with a high forecast of $18.00 and a low forecast of $11.00. The average price target represents a 21.76% upside from the last price of $12.73.
Buy
The current consensus among 4 contributing investment analysts is to buy stock in Sharps Compliance. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
9/3/2019
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/2/2019
  • 0 strong buy ratings
  • 4 buy ratings
  • 0 hold ratings
  • 0 sell ratings
3/1/2020
  • 0 strong buy ratings
  • 4 buy ratings
  • 0 hold ratings
  • 0 sell ratings
5/30/2020
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
8/28/2020
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
11/26/2020
  • 0 strong buy ratings
  • 4 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/25/2021
  • 0 strong buy ratings
  • 4 buy ratings
  • 0 hold ratings
  • 0 sell ratings
2/24/2021

Latest Recommendations

  • 0 strong buy ratings
  • 4 buy ratings
  • 0 hold ratings
  • 0 sell ratings

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
2/16/2021Lake Street CapitalBoost Price TargetBuy$13.00 ➝ $18.00Low
i
2/12/2021Barrington ResearchBoost Price TargetOutperform$13.00 ➝ $15.00Low
i
1/29/2021Barrington ResearchBoost Price TargetPositive ➝ Outperform$9.00 ➝ $13.00Low
i
1/29/2021HC WainwrightBoost Price TargetBuy$12.00 ➝ $18.00High
i
Rating by A. Dayal at HC Wainwright
12/18/2020HC WainwrightInitiated CoverageBuy$12.00Medium
i
Rating by A. Dayal at HC Wainwright
10/28/2020Stifel NicolausLower Price TargetBuy$11.50 ➝ $11.00Low
i
8/21/2020Barrington ResearchReiterated RatingBuy$9.00Medium
i
7/15/2020Lake Street CapitalInitiated CoverageBuy$10.00High
i
4/30/2020Barrington ResearchBoost Price TargetOutperform$6.00 ➝ $7.50High
i
4/8/2020Stifel NicolausBoost Price TargetBuy$6.00 ➝ $9.00High
i
Rating by Michael Hoffman at Stifel Nicolaus
2/2/2020Stifel NicolausUpgradeHold ➝ Buy$4.50 ➝ $6.00Low
i
1/29/2020Barrington ResearchReiterated RatingBuy$6.00Medium
i
10/29/2019Barrington ResearchReiterated RatingOutperform$5.00 ➝ $6.00Medium
i
Rating by K. Steinke at Barrington Research
7/24/2019Robert W. BairdInitiated CoverageBuy$4.50High
i
7/24/2019Roth CapitalInitiated CoverageBuy ➝ Buy$4.50High
i
Rating by G. Sweeney at Roth Capital
5/21/2019Barrington ResearchReiterated RatingBuy$4.50High
i
Rating by K. Steinke at Barrington Research
10/25/2018Barrington ResearchSet Price TargetBuy$5.00Medium
i
Rating by Kevin Steinke at Barrington Research
4/30/2018Stifel NicolausDowngradeBuy ➝ Hold$6.00 ➝ $4.00Medium
i
10/26/2017Stifel NicolausLower Price TargetBuy$7.00 ➝ $6.00N/A
i
8/14/2017First AnalysisUpgradeEqual Weight ➝ Overweight$8.00High
i
Rating by Joseph Munda at First Analysis
8/11/2017Stifel NicolausReiterated RatingBuy$7.00High
i
8/12/2016First AnalysisDowngradeOverweight ➝ Equal Weight$9.00 ➝ $6.00N/A
i
6/21/2016Barrington ResearchLower Price TargetOutperform$9.00 ➝ $6.00N/A
i
2/29/2016Craig HallumInitiated CoverageBuy$9.00N/A
i
Rating by M. Hewitt at Craig Hallum
(Data available from 2/25/2016 forward)
Sharps Compliance logo
Sharps Compliance Corp. provides medical, pharmaceutical, and hazardous waste management services in the United States. It offers Sharps Recovery System for the containment, transportation, treatment, and tracking of medical waste generated outside the hospital and health care facility settings; TakeAway Recovery System to treat used needles, syringes, and other used healthcare products; Route-Based Pickup Service, a medical and hazardous waste pick-up services; and MedSafe, a solution for the safe collection, transportation, and disposal of unwanted and expired ultimate-user medications. The company also provides TakeAway Medication Recovery System that facilitates the proper disposal of unused medications; Black Pail Program for Rx, a solution with minimal segregation for the disposal of various pharmaceuticals; Inhaler Disposal to collect, transport, and destroy used pharmaceutical inhalers; Hazardous Drug Spill Control Kit for the cleanup of chemotherapy and other HD spills; TakeAway Recycle System for the collection and recycling of single-use medical devices from surgical centers and other healthcare facilities; ComplianceTRAC, a Web-based compliance and training program; and Universal Waste Shipback Systems to collect, transport, and recycle light bulbs, batteries, and other mercury containing devices. In addition, it offers other solutions, such as TakeAway Environmental Return System, SharpsTracer, Sharps Secure, Needle Disposal System, Complete Needle Collection and Disposal System, Pitch-It IV Poles, Asset Return System, and Spill Kit Recovery System, as well as Sharps MWMS, a medical waste management system. The company serves customers in home health care, retail clinics and immunizing pharmacies, pharmaceutical manufacturers, professional offices, assisted living and long-term care facilities, and government agencies, as well as distributors. Sharps Compliance Corp. was founded in 1992 and is headquartered in Houston, Texas.
Read More

Today's Range

Now: $12.73
$12.70
$13.75

50 Day Range

MA: $12.52
$9.76
$14.78

52 Week Range

Now: $12.73
$4.42
$15.47

Volume

138,700 shs

Average Volume

169,461 shs

Market Capitalization

$210.20 million

P/E Ratio

181.88

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of Sharps Compliance?

The following Wall Street sell-side analysts have issued research reports on Sharps Compliance in the last twelve months: Barrington Research, HC Wainwright, Lake Street Capital, Stifel Nicolaus, TheStreet, and Zacks Investment Research.
View the latest analyst ratings for SMED.

What is the current price target for Sharps Compliance?

4 Wall Street analysts have set twelve-month price targets for Sharps Compliance in the last year. Their average twelve-month price target is $15.50, suggesting a possible upside of 21.8%. Lake Street Capital has the highest price target set, predicting SMED will reach $18.00 in the next twelve months. Stifel Nicolaus has the lowest price target set, forecasting a price of $11.00 for Sharps Compliance in the next year.
View the latest price targets for SMED.

What is the current consensus analyst rating for Sharps Compliance?

Sharps Compliance currently has 4 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe SMED will outperform the market and that investors should add to their positions of Sharps Compliance.
View the latest ratings for SMED.

What other companies compete with Sharps Compliance?

How do I contact Sharps Compliance's investor relations team?

Sharps Compliance's physical mailing address is 9220 KIRBY DRIVE STE 500, HOUSTON TX, 77054. The industrial products company's listed phone number is 713-432-0300 and its investor relations email address is [email protected] The official website for Sharps Compliance is www.sharpsinc.com.